The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Assessing Genetic Risks: Implications for Health and Social Policy
Thaddeus Kelly, M.D., Ph.D. Vice Chair American Board of Medical Genetics Division of Human Genetics University of Virginia Hospital Charlottesville, VA 22908
Katherine Klinger, Ph.D. Vice President for Science Integrated Genetics, Inc. 31 New York Avenue Framingham, MA 01701
George Knight, Ph.D. Foundation for Blood Research P.O. Box 190 Scarborough, ME 04070
Karla Matteson, Ph.D. Director, Human Development and Genetics Center University of Tennessee Medical Center 1924 Alcon Highway Knoxville, TN 37920
Douglas McQuilken Vice President for Business Development Roche Molecular Systems, Inc. 340 Kingsland Street Nutley, NJ 07110
F. John Meaney, Ph.D. Office of Risk Assessment and Investigation Division of Disease Prevention Services Arizona Department of Health Services 3008 N. 3rd Street, Suite 101 Phoenix, AZ 85012
Patricia Murphy, Ph.D. Director, DNA Diagnostic Laboratory Laboratory of Human Genetics State of New York Department of Health Wadsworth Center for Laboratories and Research Empire State Plaza Albany, NY 12201-0509
Deborah Nickerson, Ph.D. Division of Biology, 139-74 California Institute of Technology Pasadena, CA 91125
Seymour Perry, M.D. Chair Department of Family and Community Medicine Georgetown University School of Medicine 215 Kober-Cogan Building 3750 Reservoir Road Washington, DC 20007
Hope Punnett, Ph.D. ASHG Committee on Genetic Services St. Christopher's Children's Hospital Front and Erie Streets Philadelphia, PA 19134
Max Rabinowitz, M.D. Division of Clinical Laboratory Devices Office of Device Evaluation, Food and Drug Administration 1390 Piccard Drive Rockville, MD 20850